Skip to main navigation Skip to search Skip to main content

In silico identification of novel kinase inhibitors targeting wild-type and T315I mutant ABL1 from FDA-approved drugs

Huai-long Xu, Zi-jie Wang, Xiao-meng Liang, Xin Li, Zheng Shi, Nan Zhou, Jin-ku Bao

Research output: Contribution to journal › Article › peer-review

26   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'In silico identification of novel kinase inhibitors targeting wild-type and T315I mutant ABL1 from FDA-approved drugs'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science